+++ STONG BUY +++
Ausbruch und Rallye noch vor dem Wochenende?!
Anzeige
Talphera - Forum WKN: A3DWPN ISIN: US00444T2096 Kürzel: TLPH Forum: Aktien User: Summer.76
0,8305 EUR
-2,29 %-0,0195
8. Nov, 17:10:47 Uhr,
L&S Exchange
Kommentare 76
Summer.76,
07.02.2024 5:52 Uhr
0
Talphera files to sell 7.79M shares for its holders
https://seekingalpha.com/news/4063533-talphera-files-to-sell-779m-shares-for-its-holders
• Talphera (NASDAQ:TLPH) filed a prospectus related to the proposed resale of 7.79 million common shares by the selling stockholders.
• This prospectus is not an offer to sell these securities
Summer.76,
22.01.2024 19:35 Uhr
0
Talphera Price Target Raised to
$6.00/Share From $5.00 by HC
Wainwright & Co.
https://www.benzinga.com/quote/TLPH/analyst-ratings
Hawk9991,
18.01.2024 21:10 Uhr
1
Wow. Vielen Dank für die Information. Hab mich schon gefragt was plötzlich los ist. Das sind sehr gute Nachrichten. 👍
Summer.76,
18.01.2024 20:39 Uhr
0
https://www.prnewswire.com/news-releases/talphera-announces-26-million-capital-commitment-through-a-combination-of-a-non-dilutive-royalty-monetization-and-equity-offering-302037920.html
Summer.76,
09.01.2024 17:57 Uhr
0
AcelRx Announces Rebranding With Name Change to Talphera, Inc.
https://www.prnewswire.com/news-releases/acelrx-announces-rebranding-with-name-change-to-talphera-inc-302029288.html
Name change to "Talphera" reflects a new era of the Company in partnership with the medical community developing novel solutions for medically supervised settings
Talphera will begin trading on Nasdaq under the trading symbol "TLPH" effective January 10
...
Summer.76,
12.12.2023 15:55 Uhr
0
https://www.acelrx.com/news-releases/news-release-details/acelrx-pharmaceuticals-announces-publication-study-evaluating
Summer.76,
09.11.2023 6:22 Uhr
0
https://www.prnewswire.com/news-releases/acelrx-reports-third-quarter-2023-financial-results-and-provides-corporate-update-301982149.html
Summer.76,
25.09.2023 21:07 Uhr
0
https://www.publicnow.com/view/0366A8A3183E37725CF7D9F410DD0FB45637F347
...On September 22, 2023, the FDA notified the Company that due to the volume of EUA requests the FDA has received, the FDA has determined that review of the Niyad EUA is not a priority and has therefore declined to issue an EUA for Niyad at this time pursuant to the FDA's current prioritization of EUA requests. In the notice letter, the FDA encouraged the Company to continue to assess clinical development of the Niyad device. The Company plans to initiate a registrational study of Niyad later this year and anticipates submitting a Pre-Market Application ("PMA") for Niyad to the FDA in 2024. ....
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | TESLA MOTORS Hauptdiskussion | +6,60 % | |
| 2 | NVIDIA Hauptdiskussion | -0,27 % | |
| 3 | SUNRUN INC Hauptdiskussion | -18,15 % | |
| 4 | Dax Prognose | -1,18 % | |
| 5 | Phunware ab 27.02.24 RS | -7,24 % | |
| 6 | Zukunft Ocugen | -6,25 % | |
| 7 | Marathon Digital Holdings | +1,19 % | |
| 8 | Canopy Hauptforum | -7,83 % | |
| 9 | EVOTEC Hauptdiskussion | -0,29 % | |
| 10 | BAYER Hauptdiskussion | -1,67 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | TESLA MOTORS Hauptdiskussion | +6,60 % | |
| 2 | NVIDIA Hauptdiskussion | -0,27 % | |
| 3 | SUNRUN INC Hauptdiskussion | -18,15 % | |
| 4 | Phunware ab 27.02.24 RS | -7,24 % | |
| 5 | Zukunft Ocugen | -6,25 % | |
| 6 | Marathon Digital Holdings | +1,19 % | |
| 7 | Canopy Hauptforum | -7,83 % | |
| 8 | BAYER Hauptdiskussion | -1,67 % | |
| 9 | EVOTEC Hauptdiskussion | -0,29 % | |
| 10 | Phunware Hauptdiskussion | -7,24 % | Alle Diskussionen |